Novo Nordisk US stocks rose 2% before trading
因醉鞭名马幌
发表于 2023-11-2 17:32:31
294
0
0
On November 2nd local time, Novo Nordisk's US stock market rose 2% before trading. On the news, Novo Nordisk's Wegovy sales in the third quarter were 9.65 billion Danish kroner, with an expected 8.07 billion Danish kroner.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Bank of America survey: US stock market expected to be the best asset of 2025 after Trump's victory!
- Lai Lai scares, Novo Nordisk saves the scene! The market prospects of weight loss drugs still make many players salivate
- Chinese concept stocks and US stocks mostly rose before the market, with extreme discounts and a nearly 6% increase
- Most US bank stocks rise, with JPMorgan Chase exceeding 1%
- Fuguo Bank's US stock market rose nearly 3% before trading
- Novo Nordisk: All regulatory delivery conditions for Novo Nordisk's $16.5 billion acquisition of Contante have been met
- Novo Nordisk invests 8.5 billion Danish kroner to build new production facility in Odense, Denmark
- RBC Capital raises target prices for multiple US bank stocks
- Micron Technology's US stock fell more than 14% in pre-market trading
- Novo Nordisk's pre-market decline narrows to 20%
